Preparedness for AIDS vaccine trials in India

被引:0
作者
Excler, Jean-Louis [1 ]
Kochhar, Sonali [1 ]
Kapoor, Sushma [1 ]
Das, Sweta [1 ]
Bahri, Jyoti [1 ]
Ghosh, Meenakshi Datta [2 ]
Ganguly, N. K. [3 ]
Nayyar, Anjali [1 ]
Chataway, Mark
机构
[1] Int AIDS Vaccine Initiat, New Delhi 110003, India
[2] Minist Panchayati Raj, New Delhi, India
[3] Indian Council Med Res, New Delhi, India
关键词
AIDS vaccine; clinical trials; HIV; India; preparedness;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
India bears a heavy disease burden of HIV/AIDS infected and affected people. A safe, effective and accessible preventive AIDS vaccine, used along with other preventive interventions, is urgently needed to stem the epidemic. This review highlights the extensive preparedness activities undertaken from 2002 by the International AIDS Vaccine Initiative (IAVI), its Indian government and non government partners with the Indian scientific, political, media and community stakeholders and the capacity building process, before the conduct of the first ever AIDS vaccine trials in India in early 2005. Issues addressed included mistrust of clinical research due to past history of some unethical trials, transparency, community involvement, stigma and discrimination, provision for care and treatment of participants, informed consent, gender considerations, approval process, and operational aspects. The strong political support along with preparedness activities led to the successful conduct of AIDS vaccine trials enrolling equitably healthy women and men from all sections of society. This has paved the way for future vaccine trials in the country.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 53 条
[1]   Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa [J].
Amirfar, Sam ;
Hollenberg, James P. ;
Karim, Salim S. Abdool .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (02) :219-225
[2]  
AVRETT S, 2002, CAN HIV AIDS POLICY, V7, P20
[3]  
Berkley S, 1997, J Int Assoc Physicians AIDS Care, V3, P30
[4]   Thorny issues in the ethics of AIDS vaccine trials [J].
Berkley, S .
LANCET, 2003, 362 (9388) :992-992
[5]   Risk factors and clinical preservation of acute primary HIV infection in India [J].
Bollinger, RC ;
Brookmeyer, RS ;
Mehendale, SM ;
Paranjape, RS ;
Shepherd, ME ;
Gadkari, DA ;
Quinn, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2085-2089
[6]   The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia [J].
Brown, T ;
Peerapatanapokin, W .
SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 :i19-i24
[7]   The challenges of HIV vaccine development and testing [J].
Burgers, WA ;
Williamson, C .
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2005, 19 (02) :277-291
[8]  
Chakrabarti S, 2000, INDIAN J MED RES, V111, P189
[9]  
CLUMECK N, 2006, AIDS VACCINE 0829
[10]   Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials [J].
Coletti, AS ;
Heagerty, P ;
Sheon, AR ;
Gross, M ;
Koblin, BA ;
Metzger, DS ;
Seage, GR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (02) :161-169